Ghaswalla P, Carrico J, Hicks KA. The annual economic burden of respiratory syncytial virus in adults in the United States. Presented at the 2024 Biomedical Advanced Reseaerch and Development Authority George Risi Memorial Journal Club; January 22, 2024.
Colosia A, Costello J, McQuarrie K, Kato K, Bertzos K. Systematic literature review of the signs and symptoms of respiratory syncytial virus. Influenza Other Respi Viruses. 2023 Feb 5;17(2):e13100. doi: 10.1111/irv.13100
Costello J, Colosia A, Bertzos K, McQuarrie K. Systematic literature review of the signs and symptoms of respiratory syncytial virus in high-risk adults and immunocompromised populations. Poster presented at the International Society for Influenza and other Respiratory Virus Diseases (ISIRV) 2022 Conference; September 26, 2022. Belfast, United Kingdom.
Costello J, Colosia A, Kato K, Bertzos K, McQuarrie K. Systematic literature review of the signs and symptoms of respiratory syncytial virus in young children. Poster presented at the International Society for Influenza and other Respiratory Virus Diseases (ISIRV) 2022 Conference; September 26, 2022. Belfast, United Kingdom.
Qin S, Nelson L, McLeod L, Ma J, López Sánchez B, Gamil M, Stevens M, Jane Scott J. Psychometric evaluation of the pediatric RSV severity and outcomes rating system version 7 (PRESORSv7.1, observer-reported and PRESORSv7 clinician- reported forms) scores in young children hospitalized with respiratory syncytial virus infection. Presented at the 2021 Virtual Visual ISOQOL 28th Annual Conference; October 12, 2021. [abstract] Qual Life Res. 2021; 30(Suppl 1):S16-7. doi: https://doi.org/10.1007/s11136-021-02976-1
Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017 Jul;145(10):2109-21. doi: 10.1017/S0950268817000887.
Buck PO, Gordon LD, Meyers J, Parikh R, Kurosky S, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease: a US database study. Poster presented at the National Foundation for Infectious Diseases 19th Annual Conference on Vaccine Research; April 2016. Bethesda, MD.
Christiansen CF, Pedersen L, Sorensen HT, Rothman KJ. Methods to assess seasonal effects in epidemiological studies of infectious diseases-exemplified by application to the occurrence of meningococcal disease. Clin Microbiol Infect. 2012 Oct 1;18(10):963-9.
DiFranza JR, Masaquel A, Barrett AM, Colosia AD, Mahadevia PJ. Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatr. 2012 Jun 1;12:81.
Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia PJ, Yogev R. Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review. BMC Infect Dis. 2012 Apr 1;12:95.
Sansgiry SS, Joish VN, Boklage S, Goyal RK, Chopra P, Sethi S. Economic burden of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J Med Econ. 2012;15(2):219-24. doi: 10.3111/13696998.2011.638954
Earnshaw SR, Sikirica V, Roskell NS, Shannon PR, Beard S, Schein J, Doshi D, Janagap C. Economic analysis of short-course levofloxacin versus amoxicillin/clavulanate in treating acute bacterial exacerbations of chronic bronchitis. Poster presented at the Academy of Managed Care Pharmacy 19th Annual Meeting Showcase; April 14, 2007.